Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text |  PDF Volume 6 | Issue 1 | January-April 2021DOI: 10.25259/IJMIO_30_2020 |
44,597 | 3,573 | 48,170 |
Review ArticleAntibody-drug conjugate review in breast cancer: A targeted approachFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_30_2024 |
12,655 | 35,043 | 47,698 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_26_2020 |
38,978 | 4,879 | 43,857 |
Review ArticleGenetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosisFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_11_2024 |
12,189 | 29,556 | 41,745 |
Case ReportCase report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancyFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_26_2024 |
12,028 | 24,127 | 36,155 |
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_12_2023 |
28,680 | 3,151 | 31,831 |
Review ArticleEmerging strategies in cancer immunotherapy: Expanding horizons and future perspectivesFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_24_2024 |
13,327 | 17,409 | 30,736 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_20_2023 |
27,115 | 3,035 | 30,150 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_15_2023 |
26,981 | 2,899 | 29,880 |
Case ReportLong-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_16_2023 |
24,448 | 3,052 | 27,500 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_17_2023 |
23,011 | 2,212 | 25,223 |
Case ReportBreast carcinoma disguised as systemic sclerosis: A case report of unusual paraneoplastic syndromeFull text | PDF Volume 10 | Issue 1 | January-April 2025DOI: 10.25259/IJMIO_4_2024 |
7,632 | 17,083 | 24,715 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_18_2023 |
19,113 | 2,868 | 21,981 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_2_2024 |
18,178 | 3,633 | 21,811 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_3_2024 |
18,321 | 3,349 | 21,670 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Volume 6 | Issue 3 | September-December 2021 |
16,579 | 3,907 | 20,486 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_1_2024 |
17,094 | 3,038 | 20,132 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_8_2022 |
14,100 | 5,949 | 20,049 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_5_2022 |
13,158 | 6,633 | 19,791 |
Review ArticleUnderstanding immunotherapy and CAR-T-cells: A narrative reviewFull text | PDF Volume 9 | Issue 1 | January-April 2024DOI: 10.25259/IJMIO_22_2023 |
17,043 | 2,597 | 19,640 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_6_2023 |
15,608 | 2,936 | 18,544 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_21_2019 |
13,504 | 4,550 | 18,054 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_1_2022 |
12,718 | 5,232 | 17,950 |
Case ReportHyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young maleFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_16_2021 |
14,673 | 3,001 | 17,674 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_29_2022 |
14,670 | 2,882 | 17,552 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_13_2021 |
14,506 | 2,852 | 17,358 |
Review ArticleCombination of PARPi and anti-PD-L1 therapies in ovarian cancerFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_28_2022 |
15,056 | 1,977 | 17,033 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text | PDF Volume 8 | Issue 2 | May-August 2023DOI: 10.25259/IJMIO_27_2022 |
15,353 | 1,633 | 16,986 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_26_2021 |
11,459 | 5,380 | 16,839 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_2_2022 |
11,835 | 4,967 | 16,802 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text | PDF Volume 7 | Issue 3 | September-December 2022DOI: 10.25259/IJMIO_14_2022 |
11,111 | 5,094 | 16,205 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_15_2020 |
10,442 | 5,548 | 15,990 |
Review ArticleImmuno-oncological era of breast cancer: A progressive path to better treatmentFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_3_2022 |
9,790 | 6,110 | 15,900 |
Case SeriesDual driver in non-small cell lung carcinoma – therapeutic dilemmaFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_22_2021 |
12,756 | 2,937 | 15,693 |
Review ArticleImmuno-oncology of differentiated thyroid cancerFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_36_2020 |
11,296 | 4,218 | 15,514 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text | PDF Volume 8 | Issue 3 | September-December 2023DOI: 10.25259/IJMIO_11_2023 |
13,176 | 2,136 | 15,312 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_2_2021 |
10,711 | 4,557 | 15,268 |
Review ArticleThe evolving role of precision medicine in the management of advanced sarcomas – A mini reviewFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_6_2021 |
12,088 | 3,146 | 15,234 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_2_2019 |
9,223 | 5,828 | 15,051 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Volume 6 | Issue 2 | May-August 2021DOI: 10.25259/IJMIO_28_2020 |
10,736 | 4,249 | 14,985 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_12_2021 |
11,561 | 3,329 | 14,890 |
Review ArticleEndocrine toxicity of cancer immunotherapyFull text | PDF Volume 9 | Issue 2 | May-August 2024DOI: 10.25259/IJMIO_19_2024 |
13,592 | 1,261 | 14,853 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Volume 5 | Issue 2 | May-August 2020DOI: 10.25259/IJMIO_19_2019 |
9,658 | 5,033 | 14,691 |
Case ReportUnusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemmaFull text | PDF Volume 7 | Issue 1 | January-April 2022DOI: 10.25259/IJMIO_18_2021 |
11,600 | 3,016 | 14,616 |
Review ArticlePatient perspectives on living with chronic myeloid leukemia in India: Quality of life, psychosocial support, and stigmaFull text | PDF Volume 9 | Issue 3 | September-December 2024DOI: 10.25259/IJMIO_17_2024 |
13,859 | 654 | 14,513 |
Case ReportRedefining the treatment of metastatic uveal melanoma with immunotherapy – A case reportFull text | PDF Volume 7 | Issue 2 | May – August 2022DOI: 10.25259/IJMIO_11_2022 |
11,300 | 3,174 | 14,474 |
EditorialNanobytesFull text | PDF Volume 4 | Issue 3 | September-December 2019DOI: 10.25259/IJMIO_7_2019 |
6,794 | 7,542 | 14,336 |
Brief CommentaryERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginningFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_10_2021 |
10,957 | 3,226 | 14,183 |
Conference Review6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapiesFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_20_2021 |
11,533 | 2,540 | 14,073 |
Brief CommentaryBioactive lipid: A novel diagnostic approach for retinoblastoma in clinical managementFull text | PDF Volume 6 | Issue 3 | September-December 2021DOI: 10.25259/IJMIO_7_2021 |
10,661 | 3,360 | 14,021 |
